Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2003

Study Completion Date

February 28, 2011

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

bevacizumab

DRUG

capecitabine

DRUG

fluorouracil

DRUG

leucovorin calcium

DRUG

oxaliplatin

Trial Locations (52)

10011

St. Vincents Comprehensive Cancer Center, New York

10016

New York University Medical Center, New York

10504

Advanced Oncology Associates, Armonk

10595

New York Medical College, Valhalla

11021

Arena Oncology Associates, Great Neck

11733

North Shore Hematology/Oncology Associates, P.C., East Setauket

15232

Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh

19106

Pennsylvania Oncology Hematology Associates, Philadelphia

20007

Lombardi Cancer Center at Georgetown University Medical Center, Washington D.C.

21204

Greater Baltimore Medical Center and Cancer Center, Baltimore

27534

Southeastern Medical Oncology Center, Goldsboro

27710

Duke Comprehensive Cancer Center, Durham

27834

Physicians East - Quadrangle, Greenville

29403

Charleston Hematology-Oncology, P.A., Charleston

30309

Peachtree Hematology and Oncology Consultants, P.C., Atlanta

32207

Florida Oncology Associates, Jacksonville

32804

Hematology and Oncology Consultants, P.A., Orlando

33401

Palm Beach Cancer Institute, West Palm Beach

33428

Lynn Regional Cancer Center West, Boca Raton

33901

Florida Cancer Specialists, Fort Myers

34952

Hematology Oncology Associates of theTreasure Coast - Port St. Lucie, Port Saint Lucie

37203

Sarah Cannon Cancer Center at Centennial Medical Center, Nashville

37604

McCleod Cancer and Blood Center, Johnson City

38119

Memphis Cancer Center, Memphis

38120

West Clinic, Memphis

39202

Jackson Oncology Associates, PLLC, Jackson

43235

Hematology Oncology Consultants Inc, Columbus

46601

CCOP - Northern Indiana CR Consortium, South Bend

60305

West Suburban Center for Cancer Care, River Forest

60611

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

61108

Saint Anthony Medical Center, Rockford

64128

Veterans Affairs Medical Center - Kansas City, Kansas City

75230

Medical City Dallas Hospital, Dallas

76508

Center for Cancer Prevention and Care at Scott and White Clinic, Temple

78207

South Texas Oncology and Hematology, San Antonio

78759

Lone Star Oncology, Austin

80218

Rocky Mountain Cancer Centers - Midtown, Denver

83814

North Idaho Cancer Center, Coeur d'Alene

85712

Arizona Clinical Research Center, Tucson

92270

Cancer and Blood Institute of the Desert, Rancho Mirage

93534

Valley Tumor Medical Group, Lancaster

97301

Hematology/Oncology of Salem, Salem

35294-3300

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

94904-2007

California Cancer Care, Inc., Greenbrae

06790

Northwestern Connecticut Oncology-Hematology Associates, Torrington

60068-1270

Lutheran General Cancer Care Center, Park Ridge

52403-1206

Cedar Rapids Oncology Associates, Cedar Rapids

67214-3882

CCOP - Wichita, Wichita

59107-5100

Deaconess Billings Clinic Cancer Center, Billings

08043

Cooper Cancer Institute at Cooper University Hospital, Voorhees Township

27609-7300

Raleigh Hematology/Oncology Associates, P.A. - Wake Practice, Raleigh

53215-3690

Medical Consultants, Milwaukee

All Listed Sponsors
lead

Prologue Research International

INDUSTRY

NCT00062426 - Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter